![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Effect of Baseline NS5A Polymorphisms on Virologic Response to the All-Oral Combination of Daclatasvir + Sofosbuvir ± Ribavirin in Patients With Chronic HCV Infection
|
|
|
Reported by Jules Levin
The International Liver Congress™ 2014
49th Annual Meeting of the European Association for the Study of the Liver
London, UK, April 9-13, 2014
McPhee F,1 Zhou N,1 Yang X,1 Hernandez D,1 Chiarella J,2 Kozal M2
1Bristol Myers Squibb, Wallingford, CT, USA
2Yale University School of Medicine, New Haven, CT, USA
![EASL1.gif](../images/041114/041114-11/EASL1.gif)
![EASL2.gif](../images/041114/041114-11/EASL2.gif)
![EASL3.gif](../images/041114/041114-11/EASL3.gif)
![EASL4.gif](../images/041114/041114-11/EASL4.gif)
![EASL5.gif](../images/041114/041114-11/EASL5.gif)
![EASL6.gif](../images/041114/041114-11/EASL6.gif)
![EASL7.gif](../images/041114/041114-11/EASL7.gif)
![EASL8.gif](../images/041114/041114-11/EASL8.gif)
![EASL9.gif](../images/041114/041114-11/EASL9.gif)
![EASL10.gif](../images/041114/041114-11/EASL10.gif)
![EASL11.gif](../images/041114/041114-11/EASL11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|